We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

17 Jun 2026 - 19 Jun 2026
25 Jun 2026 - 27 Jun 2026
08 Jul 2026 - 10 Jul 2026

Alliance to Develop HLA-Typing Method

By HospiMedica staff writers
Posted on 24 Oct 2001
A collaborative agreement to evaluate and develop methods for typing human leukocyte antigens (HLA) using a simple-to-use sequencing technology has been announced by Pel-Freez Clinical Systems LLC (Stockholm, Sweden) and the Molecular Diagnostics Business Unit of Pyrosequencing AB (Milwaukee, WI, USA). More...
The announcement was made at the conference of the American Society for Histocompatibility and Immunogenetics in San Francisco (CA, USA).

HLA genes are highly variable, which has a significant impact on patients undergoing organ and bone marrow transplantation. To achieve the highest clinical success, the goal in transplantation is to accurately match the patterns of HLA variability of the donor and patient. DNA-based method for HLA typing have enabled diagnostic labs to better identify appropriate donors. Pel-Freez and Pyrosequencing plan to base their new typing method on proprietary technology developed by Pyrosequencing. This technology is broadly applicable for the analysis of single nucleotide polymorphisms (SNPs) and for the identification and quantification of short DNA sequences used in bacterial and viral typing.

"We believe the Pyrosequencing platform will be truly novel in the HLA field with its ability to simultaneously deliver speed, resolving power, and versatility,” said Frank Langley, president of Pel-Freez.




Related Links:
Pyrosequencing
Pel-Freez

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Digital Radiography System (Ceiling Free)
Digix CF Series
Vessel Sealing Instrument
ERGOseal
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Coredio’s CPSE is a a software-as-a-medical-device platform designed for use with consumer smartwatches and standard blood pressure cuffs in clinical and home settings under physician supervision (Photo courtesy of Coredio)

AI Platform Supports Noninvasive Remote Hemodynamic Monitoring in Heart Failure

Heart failure remains a leading cause of hospitalization in adults over 65, affecting more than 6.7 million people in the U.S. Clinicians often lose visibility into hemodynamic deterioration once patients... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.